Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
interdisciplinary research. As part of this project , you will also be embedded in a consortium, offering strong opportunities for collaboration with scientists and companies working in liposome technology, cell-free
-
-design, public governance, and public–private collaboration can contribute to more democratic forms of educational technology in European primary and secondary education. Therefore, you will conduct in
-
can be part of the selection procedures of academic staff. We do this, among other things, to prevent the unwanted transfer of sensitive knowledge and technology. To apply, please send the following
-
document representations that enhance accuracy, facilitate automation, and improve interoperability across different model types used within the organization. Context-engineering automation for agentic AI As
-
be part of the selection procedures of academic staff. We do this, among other things, to prevent the unwanted transfer of sensitive knowledge and technology. To apply, please send your curriculum
-
procedures of academic staff. We do this, among other things, to prevent the unwanted transfer of sensitive knowledge and technology. To apply, please send your curriculum vitae, including a letter of
-
procedures of academic staff. We do this, among other things, to prevent the unwanted transfer of sensitive knowledge and technology. To apply, please send your curriculum vitae, including a letter of
-
, to prevent the unwanted transfer of sensitive knowledge and technology. To apply, please send the following documents via the ‘apply now’ button: a motivation letter (max 2 pages), explaining your interest in
-
. Radboud University invites applications for a Postdoctoral Researcher to work on ScaleUA, a Horizon Europe Coordination and Support Action focused on rebuilding and integrating Ukraine’s technology
-
Pinedo Cancer Care Award Foundation. The Academy has handled the nomination and selection process since 2016. Previous laureates 2024 Together with a new generation of clinical researchers, John Haanen has